Clinical Outcome of Hybrid-Volumetric Arc Therapy (H-VMAT) for Advanced Inoperable Non-Small Cell Lung Cancer (NSCLC)

被引：0
|
作者：
Chan, Oscar S. H. [1 ]
Hung, Albert W. M. [1 ]
Chang, Amy T. Y. [1 ]
Chan, Lucy L. K. [1 ]
Chan, Connie C. C. [1 ]
Yeung, R. M. W. [1 ]
机构：
[1] Pamela Youde Nethersole Eastern Hosp, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
Volumetric Arc Therapy; intensity modulated radiotherapy; advanced NSCLC; survival;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.03-016
引用
收藏
页码：S447 / S448
页数：2
相关论文
共 50 条
  • [21] CLINICAL OUTCOME OF CHEMORADIOTHERAPY IN ELDERLY VETERANS WITH LOCALLY ADVANCED UNRESECTABLE NON-SMALL CELL LUNG CANCER (NSCLC)
    Dembla, V.
    Choi, M.
    Choong, N.
    May, W.
    Chan, W.
    Elkins, S.
    Khansur, T.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2010, 58 (02) : 483 - 484
  • [22] A novel Hybrid Volumetric Modulated Arc Therapy (H-VMAT) technique for primary cervical spine malignant tumors
    Zhang, X. L.
    Yang, R. J.
    Meng, N.
    Li, M. Z.
    Wang, J. J.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S198 - S198
  • [23] Impact of Using Volumetric Modulated Arc Therapy on Radiation Pneumonitis in Locally Advanced Non-Small Cell Lung Cancer
    Imano, N.
    Kimura, T.
    Kameoka, T.
    Ochi, M.
    Takeuchi, Y.
    Takahashi, I.
    Nishibuchi, I.
    Murakami, Y.
    Kawahara, D.
    Miki, K.
    Saito, A.
    Yasushi, N.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S635 - S635
  • [24] Phase II clinical trial of Gemcitabine and ifosfamide in inoperable non-small cell lung cancer (NSCLC)
    Cubedo, R
    Espana, P
    Provencio, M
    Jorge, M
    Sanchez, A
    ANNALS OF ONCOLOGY, 1998, 9 : 103 - 103
  • [25] Therapy of non-small cell lung cancer in the locally advanced stage (inoperable IIIA/IIIB)
    Baumann, Michael
    Dienemann, Hendrik C.
    Fietkau, Rainer
    Ruebe, Christian
    Thomas, Michael
    ONKOLOGIE, 2006, 29 : 11 - 14
  • [26] Evaluation of clinical and molecular changes in advanced non-small cell lung cancer(NSCLC)
    Pilnik, N
    Di Rienzo, J
    Spitale, L
    Grasso, R
    Henin, A
    Caminos, S
    LUNG CANCER: CURRENT TOPICS, 2001, : 65 - 70
  • [27] Radiation Pneumonitis After Volumetric Modulated Arc Therapy for Non-small Cell Lung Cancer
    Fujiwara, Masayuki
    Doi, Hiroshi
    Igeta, Masataka
    Suzuki, Hitomi
    Kitajima, Kazuhiro
    Tanooka, Masao
    Ishida, Toshihisa
    Wakayama, Tsukasa
    Yokoi, Takashi
    Kuribayashi, Kozo
    Kijima, Takashi
    Hashimoto, Masaki
    Kondo, Nobuyuki
    Matsumoto, Seiji
    Hasegawa, Seiki
    Kamikonya, Norihiko
    Yamakado, Koichiro
    ANTICANCER RESEARCH, 2021, 41 (11) : 5793 - 5802
  • [28] Personalized Therapy of Non-small Cell Lung Cancer (NSCLC)
    Gadgeel, Shirish M.
    LUNG CANCER AND PERSONALIZED MEDICINE: NOVEL THERAPIES AND CLINICAL MANAGEMENT, 2016, 890 : 203 - 222
  • [29] Induction therapy for non-small cell lung cancer (NSCLC)
    Nakamura, H
    Furukawa, K
    Ikeda, N
    Shibuya, H
    Tanaka, K
    Okunaka, T
    Hirano, T
    Sakai, M
    Saito, M
    Konaka, C
    Kato, H
    XXX WORLD CONGRESS OF THE INTERNATIONAL COLLEGE OF SURGEONS, VOLS 1-2, 1996, : 1029 - 1033
  • [30] Outcome predictors for pembrolizumab alone or with chemotherapy in advanced non-small cell lung cancer (NSCLC)
    Zullo, L.
    Cella, E.
    Paoloni, F.
    Gualtieri, M.
    Barletta, G.
    Favero, D.
    Parisi, F.
    Dellepiane, C.
    Rossi, G.
    Bennicelli, E.
    Zinoli, L.
    Cantini, L.
    Pecci, F.
    Del Mastro, L.
    Berardi, R.
    Genova, C.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S78 - S79
12345